The inhibitory effect of HMGCL on the growth and metastasis of NPC cells was reversed by treatment with the ROS inhibitor by inducing EMT (Fig. S1a), which suggests that ROS is a key mediator of HMGCL activity. The gene discussed is HMGCL; the disease is nasopharyngeal carcinoma.